ATE220407T1 - Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten - Google Patents

Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten

Info

Publication number
ATE220407T1
ATE220407T1 AT99109726T AT99109726T ATE220407T1 AT E220407 T1 ATE220407 T1 AT E220407T1 AT 99109726 T AT99109726 T AT 99109726T AT 99109726 T AT99109726 T AT 99109726T AT E220407 T1 ATE220407 T1 AT E220407T1
Authority
AT
Austria
Prior art keywords
uncharged
subunit
subunits
based polymers
phosphorus containing
Prior art date
Application number
AT99109726T
Other languages
English (en)
Inventor
James E Summerton
Dwight D Weller
Original Assignee
Antivirals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antivirals Inc filed Critical Antivirals Inc
Application granted granted Critical
Publication of ATE220407T1 publication Critical patent/ATE220407T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99109726T 1989-12-20 1990-12-20 Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten ATE220407T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45405789A 1989-12-20 1989-12-20

Publications (1)

Publication Number Publication Date
ATE220407T1 true ATE220407T1 (de) 2002-07-15

Family

ID=23803120

Family Applications (2)

Application Number Title Priority Date Filing Date
AT91902085T ATE312834T1 (de) 1989-12-20 1990-12-20 Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten
AT99109726T ATE220407T1 (de) 1989-12-20 1990-12-20 Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT91902085T ATE312834T1 (de) 1989-12-20 1990-12-20 Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten

Country Status (8)

Country Link
EP (2) EP0962463B1 (de)
JP (2) JP3398378B2 (de)
KR (1) KR0167574B1 (de)
AT (2) ATE312834T1 (de)
AU (1) AU655164B2 (de)
CA (1) CA2069869C (de)
DE (2) DE69034213T2 (de)
WO (1) WO1991009033A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166315A (en) * 1989-12-20 1992-11-24 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US5405938A (en) * 1989-12-20 1995-04-11 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
AU7135498A (en) * 1997-04-17 1998-11-11 Antivirals Inc. Method of treating restenosis by antisense targeting of cmv
US20010024783A1 (en) * 1999-01-29 2001-09-27 Avi Biopharma, Inc. Non-invasive method for detecting target RNA
KR20010102992A (ko) * 1999-01-29 2001-11-17 추후보정 표적 ｒｎａ를 검출하는 비-침입적 방법
US6875747B1 (en) 1999-05-24 2005-04-05 Avi Bio Pharma, Inc. Antisense to c-myc for treatment of polycystic kidney disease
CA2374499A1 (en) * 1999-05-24 2000-11-30 Avi Biopharma, Inc. Antisense to c-myc for treatment of polycystic kidney disease
EP1238071B1 (de) 1999-11-29 2008-04-23 Avi Biopharma, Inc. Gegen bakterielle 16s und 23s rrnas gerichtete ungeladene antisense oligonukleotide und deren verwendungen
WO2001049775A2 (en) * 2000-01-04 2001-07-12 Avi Biopharma, Inc. Antisense antibacterial cell division composition and method
AU2005327188C9 (en) 2004-07-02 2011-09-22 Avi Biopharma, Inc. Antisense antibacterial method and compound
US8067571B2 (en) 2005-07-13 2011-11-29 Avi Biopharma, Inc. Antibacterial antisense oligonucleotide and method
LT2735568T (lt) * 2006-05-10 2017-11-27 Sarepta Therapeutics, Inc. Oligonukleotido analogai, turintys katijonines jungtis tarp subvienetų
MX2010004955A (es) * 2007-11-15 2010-06-30 Avi Biopharma Inc Metodo de sintesis de oligomeros de morfolina.
AU2013202731B2 (en) * 2010-05-28 2016-04-21 Sarepta Therapeutics, Inc. Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
KR101981705B1 (ko) * 2010-05-28 2019-05-24 사렙타 쎄러퓨틱스, 인코퍼레이티드 변형된 서브유니트간 결합 및/또는 말단 그룹을 갖는 올리고뉴클레오타이드 유사체
TWI541024B (zh) 2010-09-01 2016-07-11 日本新藥股份有限公司 反義核酸
WO2012031243A2 (en) 2010-09-03 2012-03-08 Avi Biopharma, Inc. dsRNA MOLECULES COMPRISING OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
CN103154009B (zh) 2010-09-30 2015-06-10 日本新药株式会社 吗啉基核酸衍生物
KR20140097398A (ko) 2011-11-18 2014-08-06 사렙타 쎄러퓨틱스, 인코퍼레이티드 기능적으로-변형된 올리고뉴클레오티드 및 이의 서브유니트
CN108588073A (zh) 2011-12-28 2018-09-28 日本新药株式会社 反义核酸
US9920085B2 (en) * 2012-03-20 2018-03-20 Sarepta Therapeutics, Inc. Boronic acid conjugates of oligonucleotide analogues
JP6477464B2 (ja) * 2013-05-24 2019-03-06 味の素株式会社 モルフォリノオリゴヌクレオチドの製造方法
BR112016020618B1 (pt) 2014-03-12 2023-04-04 Nippon Shinyaku Co., Ltd. Oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido
PT3159409T (pt) 2014-06-17 2020-01-21 Nippon Shinyaku Co Ltd Ácido nucleico anti-sentido para utilização no tratamento da distrofia muscular de duchenne
JP6673211B2 (ja) 2014-10-14 2020-03-25 味の素株式会社 モルフォリノオリゴヌクレオチドの製造方法
WO2016117663A1 (ja) 2015-01-21 2016-07-28 味の素株式会社 沈殿促進剤およびそれを用いる沈殿化方法
US11020417B2 (en) 2015-06-04 2021-06-01 Sarepta Therapeutics, Inc Methods and compounds for treatment of lymphocyte-related diseases and conditions
HUE050061T2 (hu) 2015-09-15 2020-12-28 Nippon Shinyaku Co Ltd Antiszensz nukleinsav
WO2017047741A1 (ja) 2015-09-16 2017-03-23 日本新薬株式会社 筋萎縮症治療用アンチセンス核酸
AU2017330276B2 (en) * 2016-09-20 2022-01-20 The Regents Of The University Of Colorado, A Body Corporate Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry
US11560401B2 (en) 2018-05-10 2023-01-24 Nippon Shinyaku Co., Ltd. Method for preparing oligonucleic acid compound
JP7345466B2 (ja) 2018-06-26 2023-09-15 日本新薬株式会社 アンチセンスオリゴヌクレオチドを含有する組成物およびデュシェンヌ型筋ジストロフィーの治療へのその使用
GB201821269D0 (en) 2018-12-28 2019-02-13 Nippon Shinyaku Co Ltd Myostatin signal inhibitor
EP4059944A4 (de) 2019-11-13 2024-04-10 Nippon Shinyaku Co., Ltd. Verfahren zur herstellung einer oligonukleidsäureverbindung
EP4059943A4 (de) 2019-11-13 2024-01-31 Nippon Shinyaku Co., Ltd. Verfahren zur herstellung einer oligonukleidsäureverbindung
EP4079329A4 (de) 2019-12-19 2024-04-17 Nippon Shinyaku Co., Ltd. Antisense-nukleinsäure, die exon-skipping ermöglicht
IL294271A (en) 2019-12-26 2022-08-01 Nippon Shinyaku Co Ltd Antisense nucleic acid that induces skipping of exon 50
PE20230237A1 (es) 2020-02-28 2023-02-07 Nippon Shinyaku Co Ltd Acidos nucleicos antisentido que inducen la omision del exon 51
US20250282813A1 (en) 2021-04-09 2025-09-11 Bachem Holding Ag Pseudo solid phase protecting group and methods for the synthesis of oligonucleotides and oligonucleotide conjugates
CN117279926A (zh) 2021-04-28 2023-12-22 日本新药株式会社 低聚核酸化合物的制造方法
WO2022239863A1 (ja) 2021-05-13 2022-11-17 国立大学法人千葉大学 アンチセンスオリゴマー
AU2022279820A1 (en) 2021-05-28 2023-12-14 Sumitomo Pharma Co., Ltd. Antisense nucleic acid
JPWO2022270585A1 (de) 2021-06-23 2022-12-29
TW202308664A (zh) 2021-07-08 2023-03-01 日商日本新藥股份有限公司 腎毒性減輕劑
TW202317147A (zh) 2021-07-08 2023-05-01 日商日本新藥股份有限公司 析出抑制劑
US20240316093A1 (en) 2021-07-08 2024-09-26 Nippon Shinyaku Co., Ltd. Nephrotoxicity reducing agent
WO2023026994A1 (ja) 2021-08-21 2023-03-02 武田薬品工業株式会社 ヒトトランスフェリンレセプター結合ペプチド－薬物コンジュゲート
KR20240129006A (ko) 2021-12-27 2024-08-27 니뽄 신야쿠 가부시키가이샤 올리고 핵산 화합물의 제조 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2528107B2 (ja) * 1985-03-15 1996-08-28 サマ−トン，ジエ−ムス ポリヌクレオチド測定試薬と方法

Also Published As

Publication number Publication date
DE69034213D1 (de) 2006-01-19
EP0506830A4 (en) 1993-01-07
WO1991009033A1 (en) 1991-06-27
AU655164B2 (en) 1994-12-08
JPH05504563A (ja) 1993-07-15
EP0506830A1 (de) 1992-10-07
DE69034213T2 (de) 2006-08-24
JP2002167441A (ja) 2002-06-11
EP0962463B1 (de) 2002-07-10
KR0167574B1 (ko) 1999-01-15
EP0962463A1 (de) 1999-12-08
DE69033986D1 (de) 2002-08-14
AU7164291A (en) 1991-07-18
KR920703584A (ko) 1992-12-18
JP3398378B2 (ja) 2003-04-21
CA2069869A1 (en) 1991-06-21
ATE312834T1 (de) 2005-12-15
CA2069869C (en) 1995-12-19
EP0506830B1 (de) 2005-12-14
DE69033986T2 (de) 2003-03-13

Similar Documents

Publication Publication Date Title
ATE312834T1 (de) Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten
EP0506845A4 (en) Uncharged morpholino-based polymers having achiral intersubunit linkages
ATE81872T1 (de) Stereoregulare polynukleotiden bindende polymere.
ES2128535T3 (es) Nucleosidos y oligonucleotidos con grupos 2'-eter.
ATE130859T1 (de) Styrencopolymer und verfahren zur herstellung.
ATE186304T1 (de) Infrarot-farbstoff-markierte nucleotide und ihre verwendung in der nucleinsäure-detektion
NO912277D0 (no) Silan-tverrbindbar polymersammensetning inneholdende en silanforbindelse som et forherdings-retardasjonsmiddel.
ES2088543T3 (es) Copolimeros de monoalquil fosfinato y fosfonato de bajo peso molecular.
ES2093016T3 (es) Composicion suavizante de tejidos.
DE69127304D1 (de) Aufnahme von Gruppen in Polymere, hergestellte Polymere und diese Polymere enthaltende Zusammensetzungen
AU8168987A (en) Polymers of carbon monoxide and alpha-olefinically unsaturated compounds
ATE136321T1 (de) Polyarylensulfid-harzzusammensetzung
DE69230453D1 (de) Neue Pentaerythrityl-Phosphonate und ihre Verwendung in selbstlöschenden thermoplastischen Polymerzusammensetzungen
ES2147280T3 (es) Remate de polimeros anionicos con oxetanos.
FI935633A0 (fi) Kopolyamider med laongkedjiga polyamidenheter
ATE177128T1 (de) Mit phosphorverbindungen und einer polyolefinezusammensetzung modifiziertes bitumen
DE69019003D1 (de) Katalysator-Zusammensetzungen.
MY106165A (en) Catalyst compositions and polymerization process, hexakisphosphines and hexahalo compounds
KR880701718A (ko) 5-헤테로-또는 아릴-치환-이미다조[2,1-a]이소퀴놀린
FR2714672B1 (fr) Compositions améliorées de bitume, leur procédé de préparation et leurs applications.
ES2055773T3 (es) Combinaciones de aglutinantes y un procedimiento para la obtencion de formaciones superficiales.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time